Main Session
Sep 29
SS 15 - Radiation Biology 2: Novel immunotherapeutics & biomarker discovery

191 - Preclinical Evaluation of First-in-Class PROTAC Survivin Degrader HMAK101 for Radiosensitization for GBM, DIPG and Brain Metastases

08:30am - 08:40am PT

Presenter(s)

Shuhua Zheng, DO, PhD - Northwestern Feinberg School of Medicine, Chicago, IL